Kim Orton-Smith

Company: Abselion

Job title: VP Sales & Marketing

Seminars:

Addressing the challenge of managing inherent variability when working with AAV vectors to accelerate the development of novel gene therapies 2:20 pm

Examine the causes of analytical bottlenecks in bioprocess development when evaluating AAV vectors, where time is of the essence Highlight the importance of monitoring AAV titre to establish robustness and consistency in the process, to identify issues early and support technology transfer to GMP Discuss choosing the right AAV quantification method through a comparison of…Read more

day: Day One